Shuttle Pharmaceuticals Files 8-K
Ticker: SHPH · Form: 8-K · Filed: Nov 26, 2024 · CIK: 1757499
| Field | Detail |
|---|---|
| Company | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) |
| Form Type | 8-K |
| Filed Date | Nov 26, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
Shuttle Pharma filed an 8-K on Nov 26, 2024. Details pending.
AI Summary
Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on November 26, 2024, reporting on a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or details about material events beyond the reporting of these items.
Why It Matters
This 8-K filing indicates that Shuttle Pharmaceuticals Holdings, Inc. is providing updates or disclosures to the SEC, which could contain important information for investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting purposes and does not disclose any immediate negative events or significant financial changes.
Key Players & Entities
- Shuttle Pharmaceuticals Holdings, Inc. (company) — Registrant
- November 26, 2024 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Regulation FD Disclosure and Financial Statements and Exhibits.
What is the exact name of the registrant?
The exact name of the registrant is Shuttle Pharmaceuticals Holdings, Inc.
In which state was Shuttle Pharmaceuticals Holdings, Inc. incorporated?
Shuttle Pharmaceuticals Holdings, Inc. was incorporated in Delaware.
What is the principal executive office address for Shuttle Pharmaceuticals Holdings, Inc.?
The principal executive office address is 401 Professional Drive, Suite 260, Gaithersburg, MD 20879.
What is the telephone number for Shuttle Pharmaceuticals Holdings, Inc.?
The telephone number for Shuttle Pharmaceuticals Holdings, Inc. is (240) 430-4212.
Filing Stats: 979 words · 4 min read · ~3 pages · Grade level 12.5 · Accepted 2024-11-26 09:00:11
Key Financial Figures
- $0.00001 — ange on which registered Common Stock $0.00001 per share SHPH The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 42KB
- ex99-1.htm (EX-99.1) — 16KB
- 0001493152-24-047747.txt ( ) — 238KB
- shph-20241126.xsd (EX-101.SCH) — 3KB
- shph-20241126_lab.xml (EX-101.LAB) — 33KB
- shph-20241126_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Dated: November 26, 2024 By: /s/ Anatoly Dritschilo Name: Anatoly Dritschilo Title: Chief Executive Officer